Risk of breast cancer according to use of antidepressants, phenothiazines, and antihistamines

American Journal of Epidemiology

Volumn 150, Issue 8, 1999, Pages 861-868

  Kelly, Judith P ^a   Rosenberg, Lynn ^a   Palmer, Julie R ^a   Rao, R Sowmya ^a   Strom, Brian L ^b   Stolley, Paul D ^c   Zauber, Ann G ^d   Shapiro, Samuel ^a  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Antidepressive agents; Breast neoplasms; Case control studies; Histamine H1 antagonists; Phenothiazines; Second generation; Serotonin uptake inhibitors; Tricyclic

Indexed keywords

ANTIHISTAMINIC AGENT; PHENOTHIAZINE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; DRUG EFFECT; DRUG EXPOSURE; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PARITY; RACE DIFFERENCE; RELIGION; RISK ASSESSMENT; RISK FACTOR;

EID: 0033569712     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a010091     Document Type: Article

References (21)

1. Brandes LJ, Arron RJ, Bogdanovic RP, et al. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res 1992;52:3796-800.
2. Hilakivi-Clarke L, Wright A, Lippman ME. Neonatal antide-pressant treatment promotes DMBA-induced mammary tumor growth. Proc Am Assoc Cancer Res 1993;34:184.
3. Brandes LJ, Macdonald LM, Bogdanovic RP. Evidence that the antiestrogen binding site is a histamine or histamine-like receptor. Biochem Biophys Res Commun 1985;126:905-10.
4. Brandes LJ, Beecroft WA, Hogg GR. Stimulation of in vivo tumor growth and phorbol ester-induced inflammation by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]-ethanamine HCl, a potent ligand for intracellular histamine receptors. Biochem Biophys Res Commun 1991;179:1297-1304.
5. Brandes LJ, Warrington RC, Arron RJ, et al. Enhanced cancer growth in mice administered daily human-equivalent doses of some H1-antihistamines: predictive in vitro correlates. J Natl Cancer Inst 1994;86:770-5.
6. Linkins RW, Comstock GW. Depressed mood and development of cancer. Am J Epidemiol 1990;132:962-72.
7. Persky VW, Kempthorne-Rawson J, Shekelle RB. Personality and risk of cancer: 20-year follow-up of the Western Electric Study. Psychosom Med 1987;49:435-49.
8. Dattore PJ, Shontz FC, Coyne L. Premorbid personality differentiation of cancer and noncancer groups: a test of the hypothesis of cancer proneness. J Consult Clin Psychol 1980;48:388-94.
9. Weissman MM, Nyers JK, Thompson WD, et al. Depressive symptoms as a risk factor for mortality and for major depression. In: Erlenmeyer-Kimling L, Miller NE, eds. Life-span research on the prediction of psychopathology. Hillsdale, NJ: Lawrence Erlbaum Assoc., Inc., 1986:251-60.
10. Hahn RC, Petitti DB. Minnesota Multiphasic Personality Inventory-rated depression and the incidence of breast cancer. Cancer 1988;61:845-8.
11. Kaplan GA, Reynolds P. Depression and cancer mortality and morbidity: prospective evidence from the Alameda County Study. J Behav Med 1988;11:1-13.
12. Zonderman AB, Costa PT Jr, McCrae RR. Depression as a risk for cancer morbidity and mortality in a nationally representative sample. JAMA 1989;262:1191-5.
13. Wallace RB, Sherman BA, Bean JA. A case-control study of breast cancer and psychotropic drug use. Oncology 1982;39: 279-83.
14. Selby JV, Friedman GD, Fireman BH. Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up. Cancer Res 1989;49:5736-47.
15. Sandow N. RxList - The Internet drug index, [database online], www.rxlist.com. Copyright 1995-.
16. Shapiro S. Case-control surveillance. In: Strom BL, ed. Pharmacoepidemiology. 2nd ed. Chichester, United Kingdom: John Wiley & Sons, 1994:301-22.
17. Rosenberg L, Rao RS, Palmer JR, et al. Calcium channel blockers and the risk of cancer. JAMA 1998;279:1000-4.
18. Harlow BL, Cramer DW. Self-reported use of antidepressants or benzodiazepine tranquilizers and risk of epithelial ovarian cancer: evidence from two combined case-controls studies (Massachusetts, United States). Cancer Causes Control 1995; 6:130-4.
19. Schlesselman JJ. Case-control studies: design, conduct, analysis. New York, NY: Oxford University Press, 1982:217-67.
20. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol 1976;103:226-35.
21. Steingart AB, Cotterchio M. Do antidepressants cause, promote, or inhibit cancers? J Clin Epidemiol 1995;48:1407-12.